Literature DB >> 10881194

The crystal structure of NusB from Mycobacterium tuberculosis.

B Gopal1, L F Haire, R A Cox, M Jo Colston, S Major, J A Brannigan, S J Smerdon, G Dodson.   

Abstract

Both prokaryotes and eukaryotes regulate transcription through mechanisms that suppress termination signals. An antitermination mechanism was first characterized in bacteriophage lambda. Bacteria have analogous machinery that regulates ribosomal RNA transcription and employs host factors, called the N-utilizing (where N stands for the phage lambda N protein) substances (Nus), NusA, NusB, NusE and NusG. Here we report the crystal structure of NusB from Mycobacterium tuberculosis, the bacterium that causes tuberculosis in humans. This molecule shares a similar tertiary structure with the related Escherichia coli protein but adopts a different quaternary organization. We show that, unlike the E. coli homolog, M. tuberculosis NusB is dimeric both in solution and in the crystal. These data help provide a framework for understanding the structural and biological function of NusB in the prokaryotic transcriptional antitermination complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881194     DOI: 10.1038/75876

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  9 in total

1.  Crystal structures of transcription factor NusG in light of its nucleic acid- and protein-binding activities.

Authors:  Thomas Steiner; Jens T Kaiser; Snezan Marinkoviç; Robert Huber; Markus C Wahl
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

2.  Structural biophysics of the NusB:NusE antitermination complex.

Authors:  Ranabir Das; Sandra Loss; Jess Li; David S Waugh; Sergey Tarasov; Paul T Wingfield; R Andrew Byrd; Amanda S Altieri
Journal:  J Mol Biol       Date:  2007-11-17       Impact factor: 5.469

3.  Structural and functional analysis of the E. coli NusB-S10 transcription antitermination complex.

Authors:  Xiao Luo; He-Hsuan Hsiao; Mikhail Bubunenko; Gert Weber; Donald L Court; Max E Gottesman; Henning Urlaub; Markus C Wahl
Journal:  Mol Cell       Date:  2008-12-26       Impact factor: 17.970

4.  Crystal structures of the antitermination factor NusB from Thermotoga maritima and implications for RNA binding.

Authors:  Irena Bonin; Rudolf Robelek; Heike Benecke; Henning Urlaub; Adelbert Bacher; Gerald Richter; Markus C Wahl
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

Review 5.  Physiology of mycobacteria.

Authors:  Gregory M Cook; Michael Berney; Susanne Gebhard; Matthias Heinemann; Robert A Cox; Olga Danilchanka; Michael Niederweis
Journal:  Adv Microb Physiol       Date:  2009       Impact factor: 3.517

6.  Evolutionary comparison of ribosomal operon antitermination function.

Authors:  Kristine B Arnvig; Shirley Zeng; Selwyn Quan; Alexander Papageorge; Ning Zhang; Anuradha C Villapakkam; Catherine L Squires
Journal:  J Bacteriol       Date:  2008-08-29       Impact factor: 3.490

7.  Comparative genomics and transcriptional profiles of Saccharopolyspora erythraea NRRL 2338 and a classically improved erythromycin over-producing strain.

Authors:  Clelia Peano; Adelfia Talà; Giorgio Corti; Daniela Pasanisi; Miriana Durante; Giovanni Mita; Silvio Bicciato; Gianluca De Bellis; Pietro Alifano
Journal:  Microb Cell Fact       Date:  2012-03-08       Impact factor: 5.328

8.  Identification of divergent protein domains by combining HMM-HMM comparisons and co-occurrence detection.

Authors:  Amel Ghouila; Isabelle Florent; Fatma Zahra Guerfali; Nicolas Terrapon; Dhafer Laouini; Sadok Ben Yahia; Olivier Gascuel; Laurent Bréhélin
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

9.  An integrative in-silico approach for therapeutic target identification in the human pathogen Corynebacterium diphtheriae.

Authors:  Syed Babar Jamal; Syed Shah Hassan; Sandeep Tiwari; Marcus V Viana; Leandro de Jesus Benevides; Asad Ullah; Adrián G Turjanski; Debmalya Barh; Preetam Ghosh; Daniela Arruda Costa; Artur Silva; Richard Röttger; Jan Baumbach; Vasco A C Azevedo
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.